← Back to headlines
Albertsons' Q4 Loss Widens Due to Opioid Settlement
Albertsons reported a widened GAAP loss for its fourth quarter, primarily attributed to an opioid settlement. This financial impact overshadowed the company's announcement of a dividend and share repurchase hike.
14 Apr, 12:14 — 14 Apr, 12:14
Sources
Showing 1 of 1 sources

